ArticleInnovation (Cambridge (Mass.))2024

A causal multiomics study discriminates the early immune features of Ad5-vectored Ebola vaccine recipients.

Zhe Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.